Aurobindo Pharma Ltd has informed BSE that in terms of the issue of USD 60 Million Convertible Bonds due 2010, the Bonds are convertible at any time on or after September 20, 2005 up to August 01, 2010 by the holders of the Bonds into Equity Shares of Rs. 5/- each of the Company at a conversion price of Rs. 522.036 per share with a fixed rate of exchange on conversion at Rs. 43.3925 per US $ 1.

Accordingly, pursuant to the applications received for conversion from one of the Bondholders, the Committee of the Board of Directors of the Company at its meeting held on November 04, 2009 has considered the request and allotted 83,121 Equity Shares of Rs. 5/- each for cash at a premium of Rs. 517.036 by conversion of Bonds worth USD 1,000,000 in terms of the offer document to the FCCB holders.

Consequent to the aforesaid allotment the paid up capital of the Company has gone up from 53,765,268 Equity Shares of Rs. 5/- each to 53,848,389 Equity Shares of Rs. 5/- each.